Medical Condition News

RSS

MEDIAN Technologies receives OSEO 'Innovative Company' accreditation

MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency). This accreditation enables innovation-focused French investment funds (Fonds Communs de Placement dans l'Innovation) to invest in MEDIAN Technologies and enjoy a number of fiscal advantages.

29 Nov 2010

Pfizer, Protalix announce marketing authorization submission in Europe for taliglucerase alfa

Pfizer Inc. and Protalix BioTherapeutics, Inc. today announced the submission of a Marketing Authorization Application to the European Medicines Agency for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD)for the treatment of Gaucher disease. Taliglucerase alfa was granted Orphan Designation by the European Commission for the treatment of Gaucher disease on March 23, 2010.

29 Nov 2010

Texas Breast Specialists expands breast cancer treatment services

Texas Breast Specialists, part of Texas Oncology, has expanded its breast cancer treatment services in Dallas, McKinney, Bedford, Carrollton, and Plano, Texas to include the mobile Naviscan PEM scanner.

29 Nov 2010

Study finds light exercise may protect against osteoarthritis

People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2010

Walking may slow cognitive decline in adults with MCI, Alzheimer's disease

Walking may slow cognitive decline in adults with mild cognitive impairment (MCI) and Alzheimer's disease, as well as in healthy adults, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2010

ACS recommends annual MRI screening in women with family history of breast cancer

Women with a personal history of breast cancer should consider annual screening with MRI in addition to mammography, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2010

SaneVax Team congratulates Senator for examining NCI ethical questions

In a letter addressed to U.S. Senator Charles Grassley, the SaneVax Team congratulated the senator on his recent efforts to examine ethical questions raised by National Cancer Institute (NCI) employees accepting extensive travel sponsored by private companies and identified two senior NCI scientists who knowingly promote unreliable human papillomavirus (HPV) tests for patient care, and the development/monitoring of genotype-specific HPV vaccines to promote an unproven virology-based cervical cancer prevention business agenda.

29 Nov 2010

New strategy to prevent memory deficits in mouse model with AD

Scientists at the Gladstone Institute of Neurological Disease (GIND) in San Francisco have discovered a new strategy to prevent memory deficits in a mouse model of Alzheimer's disease (AD).

28 Nov 2010

Stem cell treatment may help treat low back pain

Lower back pain affects many people and may be caused by degeneration of the discs between the vertebrae. Treatment for the condition using stem cells may be an alternative to today's surgical procedures. This is the conclusion of a thesis presented at the University of Gothenburg, Sweden.

28 Nov 2010

Book on learning life's lessons

To understand the rules of life, we need to take the responsibility of achieving our own goals through a positive attitude. This is the primary message that the author, Alexander Sviyash, shares in How to Learn Life's Lessons and Become Life's Favorite.

26 Nov 2010

Impax initiates patent challenge in connection with SIMCOR

Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed in connection with SIMCOR® (niacin/simvastatin) extended-release tablets, 1000/20 mg.

26 Nov 2010

Study shows relationship between nasal symptoms and severe asthma

People with multi-symptom asthma more often have night-time awakenings due to asthma-symptoms, a sign of severe asthma. Researchers writing in BioMed Central's open access journal Respiratory Research have shown that asthma with multiple symptoms is more highly prevalent than previously suggested, comprising 20- 25% of all asthmatics.

26 Nov 2010

FDA extends review period of Cladribine Tablets for MS therapy

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.

26 Nov 2010

Study suggests less than 10% of UK adults with CAH receive specialist endocrine care

A new study suggests that less than 10% of the estimated 3,591 adults in the UK with the genetic condition congenital adrenal hyperplasia (CAH) receive specialist endocrine care, and that there is no standard treatment for these patients.

26 Nov 2010

Study indicates high self-rated lifetime prevalence of depression among psychiatrists

This study addresses depression and burn-out among a sample of psychiatrists collected at a professional congress. Within several constraints, the results indicate an high self-rated lifetime prevalence of depression of 41.6% among the sample. Also noteworthy is that a fifth (20.3%) of the sample showed evidence of acute depressive symptoms.

26 Nov 2010

SuperSonic signs distribution agreement with Hologic to develop breast ultrasound market in the U.S

SuperSonic Imagine, the innovative producer of ultrasound equipment, announced today that it has signed an exclusive distribution agreement with Hologic, Inc. to develop the breast ultrasound market in the United States.

From Hologic, Inc. 26 Nov 2010

Children with high BMI have adverse heart disease risk factors at adolescence

Children who have a high body mass index (BMI) between 9 and 12 years of age are more likely to have high blood pressure, cholesterol and blood insulin levels (all risk factors for developing heart disease) by the time they reach adolescence, according to a study published today.

26 Nov 2010

Personalized oncology requires new paradigm for drug development, experts say

Millions of cancer patients worldwide may soon be able to receive more effective, personalized treatments for their disease thanks to developments in the understanding of cancer biology, experts will say at the Cancer Biology for Clinicians Symposium organized by the European Society for Medical Oncology (ESMO) in Nice this week.

25 Nov 2010

Newfoundland and Labrador have highest rate of diabetes prevalence in Canada: Report

Today, the Canadian Diabetes Association released the findings from its Newfoundland and Labrador Diabetes Cost Model, stating that Newfoundland and Labrador currently has the highest rate of diabetes prevalence in Canada, with future forecasts continuing to grow at an alarming rate.

25 Nov 2010

Phase 3 trial: TYSABRI improves vision in MS patients

Results recently presented from a study of multiple sclerosis (MS) patients taking TYSABRI (natalizumab) are supported by a Canadian woman's improved vision since starting the therapy.

25 Nov 2010

Medical Condition News

MEDIAN Technologies receives OSEO 'Innovative Company' accreditation

Pfizer, Protalix announce marketing authorization submission in Europe for taliglucerase alfa

Texas Breast Specialists expands breast cancer treatment services

Study finds light exercise may protect against osteoarthritis

Walking may slow cognitive decline in adults with MCI, Alzheimer's disease

ACS recommends annual MRI screening in women with family history of breast cancer

SaneVax Team congratulates Senator for examining NCI ethical questions

New strategy to prevent memory deficits in mouse model with AD

Stem cell treatment may help treat low back pain

Book on learning life's lessons

Impax initiates patent challenge in connection with SIMCOR

Study shows relationship between nasal symptoms and severe asthma

FDA extends review period of Cladribine Tablets for MS therapy

Study suggests less than 10% of UK adults with CAH receive specialist endocrine care

Study indicates high self-rated lifetime prevalence of depression among psychiatrists

SuperSonic signs distribution agreement with Hologic to develop breast ultrasound market in the U.S

Children with high BMI have adverse heart disease risk factors at adolescence

Personalized oncology requires new paradigm for drug development, experts say

Newfoundland and Labrador have highest rate of diabetes prevalence in Canada: Report

Phase 3 trial: TYSABRI improves vision in MS patients

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News